Page Contents
Fred Hutch Cancer Center offers comprehensive care for kidney cancer, from stage I (1) to stage IV (4). This includes advanced kidney cancer treatments and new options available only through clinical trials. The most common treatments for kidney cancer are surgery and immunotherapy. Often, patients have a combination of treatments. But not everyone needs all of these. We’ll tailor your treatment to you.
Kidney Cancer Care Tailored to You
You and your family are our top priority. At Fred Hutch Cancer Center, we offer comprehensive and compassionate care — personalized to you. You'll have access to the latest treatment options, clinical trials and supportive care services.
Kidney Cancer Multispecialty Clinic
At Fred Hutch, some people with kidney cancer see providers at our Kidney Cancer Multispecialty Clinic. At this clinic, all the specialists who will be part of your care come together. They discuss treatment options and design treatment to meet your needs. You will receive a multidisciplinary treatment plan in a single day. Learn more about the Kidney Cancer Multispecialty Clinic.
How We Treat Kidney Cancer at Fred Hutch
There are more kidney cancer treatment options than ever before. Although the most common treatment for localized kidney cancer is still surgery, many new immunotherapies and targeted therapies have been approved by the U.S. Food and Drug Administration (FDA) in recent years to treat metastatic kidney cancer. We match your treatment plan to your cancer stage and situation.
Radiation Therapy
Radiation therapy is typically used to treat kidney cancer that has spread to other parts of the body, especially the brain or bones. Radiation therapy is painless and noninvasive, and each treatment takes only minutes.
Radiation may be used:
- To help with symptoms of advanced kidney cancer, such as pain or bleeding
- To prevent symptoms from tumors growing in critical areas, such as the brain or spinal cord
Different types of radiation are used for different situations. Two examples are radiosurgery and intensity-modulated or image-guided radiotherapy (IMRT/IGRT).
Radiosurgery
Radiosurgery is an advanced form of highly focused, high-dose radiation therapy that can kill tumors in fewer treatments than conventional radiation treatment — usually one to five sessions rather than daily sessions for several weeks. It has a greater than 95% chance of killing small tumors.
There are many names for this type of treatment, such as:
- Stereotactic body radiation therapy (SBRT)
- Stereotactic ablative body radiotherapy (SABR)
- CyberKnife or Gamma Knife (brand names)
Gamma Knife is specifically designed for treating tumors in the brain. It is not an actual knife or scalpel (neither is CyberKnife) — instead, it uses carefully focused beams of radiation. Patients are usually treated in one session.
IMRT/IGRT
To do IMRT/IGRT, a physician will use computed tomography (CT) to scan the tumor and create beams of radiation that closely match the tumor's shape. The beams have different shapes and intensities (strengths), so they can deliver a higher dose of radiation to the tumor and lower doses to nearby healthy tissue.
Targeted Therapy
Targeted therapies work in a more focused way than chemotherapy. Often used for advanced kidney cancer, these therapies may shrink tumors and control their growth for long periods.
Targeted therapies commonly used for kidney cancer include:
- Axitinib: Inhibits tyrosine kinases and is used for people who have not responded to other medicines.
- Cabozantinib: A tyrosine kinase inhibitor (TKI) and anti-angiogenesis (preventing the growth of new blood vessels that tumors need to grow) medicine that blocks MET oncogene signaling.
- Everolimus: Blocks mTOR and is typically used after other medicines, such as sorafenib or sunitinib, have been tried.
- Lenvatinib: A TKI and anti-angiogenesis medicine that blocks signaling through FGFR (fibroblast growth factor receptor).
- Pazopanib: A TKI and anti-angiogenesis medicine.
- Sunitinib: A TKI that works by preventing the growth of new blood vessels that tumors need to grow (anti-angiogenesis effect) and blocking cells from dividing and multiplying.
- Tivozanib: A TKI and anti-angiogenesis medicine used for people who have not responded to other medicines.
Your care team will talk with you about the specific drugs we recommend for you, how you will receive them, your treatment schedule and what to expect. We will also explain how to take the best possible care of yourself during treatment and after, and we will connect you with medical and supportive care resources at Fred Hutch
At Fred Hutch, we understand this may be one of the most intense and challenging experiences you and your family ever go through. We are here to provide the care you need.
Your physician, supported by a team of kidney cancer experts:
- Decides on the best direction to take to start therapy
- Thinks about the standard of care for your subtype
- Looks into any clinical trials that match your needs, so you can think about joining them
Your physician will walk you and your caregiver through your treatment plan. You will have a chance to discuss your personal preferences and options, and you will decide together how to move forward.
The treatment plan we design for you depends on many factors, including:
- Your kidney cancer subtype, because different subtypes start, grow and respond to treatments differently
- If your kidney cancer is slow-growing (indolent) or fast-growing (aggressive)
- The stage of your disease
- If you have had treatment for kidney cancer in the past
- Your age and overall health
- Your needs and preferences, like what type of treatment schedule works in your life and if you want to join a clinical trial
Fred Hutch offers all standard treatment for kidney cancer. Our patients also have access to newer options or treatment combinations that you can only get through clinical trials.
Fred Hutch researchers are always looking for better ways to treat kidney cancer. We are doing clinical trials of new drugs and drug combinations to treat different types of kidney tumors. Our scientists are also developing new methods to tell which tumors are likely to respond best to which treatments.
Learn more about kidney cancer research.
If your loved one is getting targeted therapy, immunotherapy, radiation therapy or chemotherapy, there are many ways you can help. Caregiving during active treatment for kidney cancer often means doing tasks like these:
- Keeping track of their appointments and driving them to and from treatment
- Watching for changes in their condition and telling their care team about any symptoms
- Providing physical care, like helping them take medicines
- Spending time with them and encouraging them
- Taking care of tasks at home that they might not be able to do, like grocery shopping and cleaning
View resources for caregivers.